One stock that has been in breakout mode over the past couple weeks is certainly OrganiGram Holdings Inc (OTCMKTS:OGRMF). The pot stocks have been back on the move, but this may be one of the most interesting right now. The space is surging with consolidation energy following the big move (Aurora for MedReleaf) that took place last week. But there are clear catalysts in play here all their own. As a case in point, the company just announced that it has received a “Permit to Export Cannabis” from Health Canada that will allow the Company to begin its first international shipments.

According to the release, “Organigram will now be able to ship dried cannabis products to Cannatrek Medical PTY Ltd, a licensed Australian medical cannabis enterprise with operations in Melbourne, Victoria through its broker Cannada Management Group Global Inc., a leading global cannabis and hemp brokerage firm for import/export, procurement and logistics of cannabis and hemp related products.”

OrganiGram Holdings Inc (OTCMKTS:OGRMF) trumpets itself as a company that produces and sells medical marijuana in Canada. The company was founded in 2013 and is based in Moncton, Canada.

According to company materials, OrganiGram Holdings Inc. is a TSX Venture Exchange listed company whose wholly owned subsidiary, OrganiGram Inc., is a licensed producer of medical marijuana in Canada. OrganiGram is focused on producing the highest quality, condition-specific medical marijuana for patients in Canada.

FREE CONFIDENTIAL REPORT 3 Stocks Set To Soar By October 1st, 2020 SUBSCRIBE! You have Successfully Subscribed!

OGRMF’s facility is located in Moncton, New Brunswick and the Company is regulated by the Access to Cannabis for Medical Purposes Regulations.

According to company materials, “From the day we started back in 2013, it’s been about making lives better – for our clients, our people, and our community. We’re based in Moncton, New Brunswick, the heart of the Maritimes, but at OrganiGram Holdings we’re committed to improving the quality of life for Canadians across the country. For us, this means working with health-care providers and industry organizations, supporting research and education, and providing a safe, effective product. To be effective in that last goal, we made a decision to produce organic cannabis. Growing certified organic medical cannabis isn’t easy, in fact, most licensed producers won’t take this on. It means more care, more testing, more rules… but in the end, it means a product that we feel delivers on our goals in the best way. And improving the quality of life for Canadians is not just about getting safe, quality product to them effectively. It’s about creating jobs, being good neighbors and contributing to our community.”

Find out when $OGRMF reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

Traders will note 30% piled on for shareholders of the name during the trailing month. What’s more, the name has seen a growing influx of trading interest, with the stock’s recent average trading volume running 35% beyond what we have been seeing over the larger time frame.

“Today we are proud to announce our ability to commence international sales through the receipt of a Permit to Export Cannabis from Health Canada,” says Greg Engel, CEO, Organigram. “This is only the beginning. Last week we announced our intentions to invest in and sell to a German distributor. Today we announce our ability to sell into Australia. We continue to strive towards becoming a global leader in the medical cannabis trade.”

Cannatrek CEO, Tommy Huppert, commented, “We are very excited to have established a relationship with Organigram. The import of medical cannabis products from a leading Canadian licensed producer strongly positions Cannatrek to capitalize on the rapidly evolving medical cannabis industry in Australia and increase patient access.”

Currently trading at a market capitalization of $464.5M, OGRMF has a significant war chest ($53.7M) of cash on the books, which is balanced by about $398K in total current liabilities. OGRMF is pulling in trailing 12-month revenues of $10.4M. In addition, the company is seeing recent top-line growth, with sequential quarterly revenues growing at 37.3%. We will update the story again soon as further details emerge. Sign-up for continuing coverage on shares of $OGRMF stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in $OGRMF, either long or short, and we have not been compensated for this article.